Abstract
AB is a 17-year-old girl who has migraines with aura and presents for contraceptive management. Based on the US Medical Eligibility Criteria for Contraceptive Use, estrogen-containing contraceptives are contraindicated for AB due to an elevated risk of thrombosis given her diagnosis of migraines with aura. After determining which contraceptive methods are safe, comprehensive counseling should start with a discussion of the most effective contraceptive methods including intrauterine devices (IUDs) and subdermal contraceptive implants. AB elects to have an IUD placed which is inserted the same day given it is reasonably certain she is not pregnant and no sedation is required prior to IUD placement. The only mandatory examination needed prior to IUD placement is a bimanual examination and cervical inspection in accordance with the US Selected Practice Recommendations for Contraceptive Use. Finally, condom use at every sexual encounter is recommended to reduce the risk for sexually transmitted infections.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR. 2016;65(RR-04):1–66. 10.15585/mmwr.rr6504a1.
Curtis KM, Tepper NK, Jatlaoui TC, et al. U.S. medical eligibility criteria for contraceptive use, 2016. MMWR. 2016;65(RR-03):1–104. 10.15585/mmwr.rr6503a1.
Centers for Disease Control and Prevention. Summary chart of U.S. medical eligibility criteria for contraceptive use. 2016. Available via CDC. http://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf. Accessed 29 July 2016.
Trenor CC, Chung RJ, Michelson AD, et al. Hormonal contraception and thrombotic risk: a multidisciplinary approach. Pediatrics. 2011;127(2):347–57. https://doi.org/10.1542/peds.2010-2221.
Spector JT, Kahn SR, Jones MR, et al. Migraine headache and ischemic stroke risk: an updated meta-analysis. Am J Med. 2010;123(7):612–24. https://doi.org/10.1016/j.amjmed.2009.12.021.
Beksinska ME, Smit JA, Kleinschmidt I, et al. Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, non-users and discontinuers of hormonal contraception. Contraception. 2010;81(1):30–4. https://doi.org/10.1016/j.contraception.2009.07.007.
Centers for Disease Control and Prevention. Providing quality family planning services: recommendations of CDC and the U.S. Office of Population Affairs. MMWR. 2014;63(RR-04):1–54.
Secura GM, Madden T, McNicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371(14):1316–23. https://doi.org/10.1056/NEJMoa1400506.
American Academy of Pediatrics. Contraception for adolescents. Pediatrics. 2014;134(4):1257–81. https://doi.org/10.1542/peds.2014-2300.
Peipert JF, Zhao Q, Allsworth JE, et al. Continuation and satisfaction of reversible contraception. Obstet Gynecol. 2011;117(5):1105–13. https://doi.org/10.1097/AOG.0b013e31821188ad.
American College of Obstetricians and Gynecologists. ACOG committee opinion no. 518: intimate partner violence. Obstet Gynecol. 2012;119:412–7. https://doi.org/10.1097/AOG.0b013e318249ff74.
American College of Obstetricians and Gynecologists. ACOG committee opinion no. 554: reproductive and sexual coercion. Obstet Gynecol. 2013;121:411–5. https://doi.org/10.1097/01.AOG.0000426427.79586.3b.
Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussell J, Stewart F, et al., editors. Contraceptive technology. 18th ed. New York: Ardent Media, Inc.; 2004.
Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007. https://doi.org/10.1056/NEJMoa1110855.
Funk S, Miller MM, Mishell DR, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71(5):319–26.
Hova GG, Skjeldestada FE, Hilstadb T. Use of IUD and subsequent fertility – follow-up after participation in a randomized clinical trial. Contraception. 2007;75(2):88–92.
Stoddard AM, Xu H, Madden T, et al. Fertility after intrauterine device removal: a pilot study. Eur J Contracept Reprod Health Care. 2015;20(3):223–30. https://doi.org/10.3109/13625187.2015.1010639.
Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Contraception. 2009;91(5):1646–53. https://doi.org/10.1016/j.fertnstert.2008.02.140.
Beatty MN, Blumenthal PD. The levonorgestrel-releasing intrauterine system: safety, efficacy, and patient acceptability. Ther Clin Risk Manag. 2009;5:561–74.
American College of Obstetricians and Gynecologists. Practice bulletin 121: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2011;118:184–96.
Eisenberg DL, Schreiber CA, Turok DK, et al. Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system. Contraception. 2015;92(1):10–6. https://doi.org/10.1016/j.contraception.2015.04.006.
Nelson A, Apter D, Hauck B, et al. Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol. 2013;122:1205–13. https://doi.org/10.1097/AOG.0000000000000019.
Lopez LM, Bernholc A, Zeng Y, et al. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2015;(7):CD007373. doi:https://doi.org/10.1002/14651858.CD007373.pub3.
Hubacher D, Reyes V, Lillo S, et al. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006;195(5):1272–7.
Sääv I, Aronsson A, Marions L, et al. Cervical priming with sublingual misoprostol prior to insertion of an intrauterine device in nulliparous women: a randomized controlled trial. Hum Reprod. 2007;22(10):2647–52.
Johnson BA. Insertion and removal of intrauterine devices. Am Fam Physician. 2005;71(1):95–101.
Friedlander E, Kaneshiro B. Therapeutic options for unscheduled bleeding associated with long-acting reversible contraception. Obstet Gynecol Clin North Am. 2015;42(4):593–603. https://doi.org/10.1016/j.ogc.2015.07.004.
Madden T, Proehl S, Allsworth JE, et al. Naproxen or estradiol for bleeding and spotting with the levonorgestrel intrauterine system: a randomized controlled trial. Am J Obstet Gynecol. 2012;206(129):e1–8. https://doi.org/10.1016/j.ajog.2011.09.021.
Krajewski CM, Geetha D, Gomez-Lobo V. Contraceptive options for women with a history of solid-organ transplantation. Transplantation. 2013;95(10):1183–6. https://doi.org/10.1097/TP.0b013e31827c64de.
Sucato GS, Murray PJ. Developmental and reproductive health issues in adolescent solid organ transplant recipients. Semin Pediatr Surg. 2006;15(3):170–8.
Maddox DD, Rahman Z. Etonogestrel (Implanon), another treatment option for contraception. Drug Forecast. 2008;33(6):337–47.
Recommended Reading
American Academy of Pediatrics. Policy statement: contraception for adolescents. Pediatrics. 2014;134(4):1244–56. https://doi.org/10.1542/peds.2014-2299.
American College of Obstetricians and Gynecologists. ACOG Committee Opinion No. 642: increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol. 2015;126(412-417):44–8.
Centers for Disease Control and Prevention. Effectiveness of family planning methods. 2010. Available at https://www.cdc.gov/reproductivehealth/unintendedpregnancy/pdf/contraceptive_methods_508.pdf. Accessed 20 July 2016.
Centers for Disease Control and Prevention. Summary chart of U.S. medical eligibility criteria for contraceptive use. 2016. Available at http://www.cdc.gov/reproductivehealth/contraception/pdf/summary-chart-us-medical-eligibility-criteria_508tagged.pdf. Accessed 29 July 2016.
Curtis KM, Jatlaoui TC, Tepper NK, et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR. 2016;65(RR-04):1–66. 10.15585/mmwr.rr6504a1.
Guttmacher Institute. An overview of minors’ consent law as of March 1, 2016. State Policies in Brief. 2016. Available at https://www.guttmacher.org/sites/default/files/pdfs/spibs/spib_OMCL.pdf. Accessed 2 Aug 2016.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Northridge, J.L., Maslyanskaya, S. (2018). Case of a Girl Seeking Birth Control. In: Talib, H.J. (eds) Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-66978-6_18
Download citation
DOI: https://doi.org/10.1007/978-3-319-66978-6_18
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-66977-9
Online ISBN: 978-3-319-66978-6
eBook Packages: MedicineMedicine (R0)